Inmedical Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $879K

  • Investors
  • 9

Inmedical Therapeutics General Information

Description

Developer of a gel-based device designed for healing of wounds. The company's device covers bedsores produced by resection to prevent complications such as the risk of delayed bleeding due to post-intervention perforation, enabling clients to help in active treatment and physiological healing of tissues while offering a mechanical-protective barrier that regenerates the colonic mucosa.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Calle Albert Einstein, 15
  • Parque tecnológico de Álava
  • 01510 Vitoria-Gasteiz
  • Spain
+34 945
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Calle Albert Einstein, 15
  • Parque tecnológico de Álava
  • 01510 Vitoria-Gasteiz
  • Spain
+34 945

Inmedical Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inmedical Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 17-Jan-2024 $879K Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 01-Sep-2023 Completed Startup
To view Inmedical Therapeutics’s complete valuation and funding history, request access »

Inmedical Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Inmedical Therapeutics’s complete cap table history, request access »

Inmedical Therapeutics Patents

Inmedical Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024294287-A1 Topical composition for the treatment of mucosal lesions with short gelling time Pending 20-Jul-2023
EP-4746930-A1 Topical composition for the treatment of mucosal lesions with short gelling time Pending 20-Jul-2023
US-20260041705-A1 Topical composition for the treatment of mucosal lesions with short gelling time Pending 20-Jul-2023
US-20260294959-A1 Topical composition for the treatment of mucosal lesions with short gelling time Pending 20-Jul-2023
WO-2025017165-A1 Topical composition for the treatment of mucosal lesions with short gelling time Inactive 20-Jul-2023 A61L24/0015
To view Inmedical Therapeutics’s complete patent history, request access »

Inmedical Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Basque FCR Corporation Minority
Gestión de Capital Riesgo del País Vasco Venture Capital Minority
i+Med, S. Coop Corporation Minority
Jambo Healthcare Venture Capital Minority
Lizaluc Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Inmedical Therapeutics FAQs

  • When was Inmedical Therapeutics founded?

    Inmedical Therapeutics was founded in 2020.

  • Where is Inmedical Therapeutics headquartered?

    Inmedical Therapeutics is headquartered in Vitoria-Gasteiz, Spain.

  • What industry is Inmedical Therapeutics in?

    Inmedical Therapeutics’s primary industry is Therapeutic Devices.

  • Is Inmedical Therapeutics a private or public company?

    Inmedical Therapeutics is a Private company.

  • What is the current valuation of Inmedical Therapeutics?

    The current valuation of Inmedical Therapeutics is .

  • What is Inmedical Therapeutics’s current revenue?

    The current revenue for Inmedical Therapeutics is .

  • How much funding has Inmedical Therapeutics raised over time?

    Inmedical Therapeutics has raised $879K.

  • Who are Inmedical Therapeutics’s investors?

    Basque FCR, Gestión de Capital Riesgo del País Vasco, i+Med, S. Coop, Jambo Healthcare, and Lizaluc are 5 of 9 investors who have invested in Inmedical Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process